Hemab raises $135 million series B for bleeding and thrombotic disorders By / On February 24, 2023 / At 9:37 pm / In Chemical world 13 Views Post Content Post navigation Prev PostUK national facility poised to expand use of state-of-the-art electron diffraction Next PostLanzaTech completes SPAC merger You May Also Like Chemists create chiral molecules using cobalt catalysts and a zap of electricity On March 28, 2023 | In Chemical world New Jersey sues Dow Chemical and others over 1,4-dioxane pollution On March 28, 2023 | In Chemical world Sentencing delayed again for Harvard’s former chemistry head On March 28, 2023 | In Chemical world
By 
